IP Library Granted Patent US 11,793,950
Granted Patent B2
US 11,793,950 · App. 16/071,648 · Granted Oct 24, 2023

Medicament delivery device and method

Inventor: Ari Isaacs (Oceanside, NY)
Assignees: PROPEL-AIR BIOPHARMA, LLC; ACERUS BIOPHARMA INC.
A61M15/0015A61J7/0053A61M11/02A61M15/0013A61M15/0098A61M15/08A61M31/00A61M15/0043A61M25/04A61M2025/0226A61M2202/064A61M2205/075
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,793,950
App. No.
16/071,648
Granted
Oct 24, 2023
Kind
B2
Abstract

A medicament delivery device is provided having an oral tubular section for placement in the mouth of a user and a nasal tubular section for placement in the naris of a user. A medicament located in a corrugated, or flexible, section joining the oral tubular section and the nasal tubular section is dispersed into the nasal cavity of the user by blowing into the oral tubular section. A pinch valve or a one way valve is used to prevent the user from accidentally inhaling the medicament. The medicament delivery device may also be used as a pulmonary delivery device into the mouth of a user.

Claims (40)

1. A medicament delivery device comprising:

a first tubular section;

a second tubular section;

a bendable corrugated section connecting the first tubular section to the second tubular section;

a cap having a medicament chamber holding a medicament and including a sealing member,

a one way valve coupled to an exterior of the second tubular section, wherein the one way valve is configured so as to allow airflow from the second tubular section to the first tubular section and to restrict airflow from the first tubular section to the second tubular section,

wherein the one way valve has a widened body in line with the second tubular section, and the widened body has a greater cross-sectional diameter than second tubular section;

wherein a proximal end of the first tubular section is located within the cap and abuts the sealing member,

wherein the removal of the sealing member causes the medicament to flow through the first tubular section and into corrugations of the bendable corrugated section in a first direction, and

wherein the medicament exits the first tubular section in a second opposite direction during use of the medicament delivery device,

wherein the one way valve comprises:

an air inlet section having a tapered valve seal, an air inlet, and a first mating portion,

wherein the air inlet section is inserted over a first section of the second tubular section;

an air outlet section having an abutment surface, an air outlet, and a second mating portion,

wherein the air outlet is inserted over a second section of the second tubular section,

wherein the first mating portion is jointed to the second mating portion;

a shaft having a first valve stem, a tapered sealing gasket formed circumscribing the shaft, and a second valve stem,

wherein the first valve stem is coupled to a first side of the tapered sealing gasket,

wherein the second valve stem is coupled to a second side of the tapered sealing gasket

wherein the shaft has a proximal end and a distal end, and

wherein the tapered sealing gasket is formed circumscribing the shaft; and

a spring surrounding the first valve stem,

wherein a proximal end of the spring is configured so as to abut the abutment surface and a distal end of the spring is configured so as to exert a biasing force against the tapered sealing gasket, causing the tapered sealing gasket to form an airtight connection with the tapered valve seal to restrict airflow from the air outlet section to the air inlet section,

wherein the first valve stem has a cross-bar shape,

wherein the second valve stem has the cross-bar shape, and

wherein the cross-bar shape is an X-shape.

2. The medicament delivery device according to claim 1 , further comprising:

a second one way valve located in series with the one way valve along the interior of the second tubular section wherein the one way valve is located.

3. The medicament delivery device according to claim 1 , wherein, when the air inlet receives an airflow force greater than the biasing force of the spring, the spring is compressed and the airtight connection is removed, allowing airflow from the air inlet to the air outlet.

4. The medicament delivery device according to claim 1 , further comprising:

a nasal fitting located on the first tubular section;

wherein the nasal fitting is configures so as to form an airtight seal with the naris of a user when the nasal fitting is inserted into the naris, and

wherein the nasal fitting comprises a plurality of multi-tiered pliable rings of increasing diameter.

5. The medicament delivery device according to claim 4 , wherein the nasal fitting is without separations between the rings.

6. The medicament delivery device according to claim 5 , further comprising:

a cone-shaped tip located at the proximal end of the first tubular section, and

wherein the cone-shaped tip extends beyond the nasal fitting such that the cone-shaped tip is located completely within a nasal cavity of the user when the nasal fitting is inserted into the naris of the user.

7. The medicament delivery device according to claim 6 , wherein sides of the proximal end of the first tubular section are angled inwards at 30-40° to form the cone-shaped tip.

8. The medicament delivery device according to claim 7 , wherein the sides of the proximal end of the first tubular section are angled inwards at 38°.

9. The medicament delivery device according to claim 1 , wherein the first valve stem is longer than the second valve stem.

Assignments (3)
SECURITY INTEREST Recorded Dec 22, 2023
From: ACERUS BIOPHARMA INC.
To: FIRST GENERATION CAPITAL INC.
Reel/Frame 065943/0920 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 15, 2021
From: IP MED, INC.
To: PROPEL-AIR BIOPHARMA, LLC
Reel/Frame 058111/0658 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 20, 2018
From: ISAACS, ARI
To: IP MED, INC.; ACERUS BIOPHARMA INC.
Reel/Frame 046414/0021 →